Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-2-24
pubmed:abstractText
To evaluate the effects of TGF-beta1 and doxycycline on production of gelatinase MMP-9 and activation of Smad, c-Jun N-terminal kinase (JNK), extracellular-regulated kinase (ERK), and p38 mitogen-activated protein kinase (MAPK) signaling pathways in human corneal epithelial cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Doxycycline, http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP..., http://linkedlifedata.com/resource/pubmed/chemical/JNK Mitogen-Activated Protein..., http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/SMAD2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Smad2 Protein, http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1, http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0146-0404
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
840-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15728539-Anti-Bacterial Agents, pubmed-meshheading:15728539-Blotting, Northern, pubmed-meshheading:15728539-Blotting, Western, pubmed-meshheading:15728539-Cells, Cultured, pubmed-meshheading:15728539-DNA-Binding Proteins, pubmed-meshheading:15728539-Dose-Response Relationship, Drug, pubmed-meshheading:15728539-Doxycycline, pubmed-meshheading:15728539-Epithelium, Corneal, pubmed-meshheading:15728539-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:15728539-Humans, pubmed-meshheading:15728539-JNK Mitogen-Activated Protein Kinases, pubmed-meshheading:15728539-Matrix Metalloproteinase 9, pubmed-meshheading:15728539-Mitogen-Activated Protein Kinases, pubmed-meshheading:15728539-RNA, Messenger, pubmed-meshheading:15728539-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15728539-Signal Transduction, pubmed-meshheading:15728539-Smad2 Protein, pubmed-meshheading:15728539-Trans-Activators, pubmed-meshheading:15728539-Transforming Growth Factor beta, pubmed-meshheading:15728539-Transforming Growth Factor beta1, pubmed-meshheading:15728539-p38 Mitogen-Activated Protein Kinases
pubmed:year
2005
pubmed:articleTitle
Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
pubmed:affiliation
Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't